Urine Congo red test for the detection of preeclampsia in pregnant women presenting with suspected preeclampsia

References

• Steegers EAP, von Dadelszen P, Duvekot JJ, et al. Pre-eclampsia. Lancet. 2010;376(9741):1–9. doi: 10.1016/S0140-6736(10)60279-6.
   PubMed Web of Science ®Google Scholar
• Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33(3):130–137. doi: 10.1053/j.semperi.2009.02.010.
   PubMed Web of Science ®Google Scholar
• Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222. Obstet Gynecol. 2020;135(6):e237–e260. doi: 10.1097/aog.0000000000003891.
   PubMed Web of Science ®Google Scholar
• Boyle EM. Hypertension at late preterm gestation: deliver immediately or watch and wait? Acta Paediatr. 2017;106(8):1367–1368. doi: 10.1111/apa.13802.
   PubMed Web of Science ®Google Scholar
• ACOG Practice Bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 2002;77(1):67–75.
   PubMed Web of Science ®Google Scholar
• Milne F, Redman C, Walker J, et al. Assessing the onset of pre-eclampsia in the hospital day unit: summary of the pre-eclampsia guideline (PRECOG II). BMJ. 2009;339(3):b3129. doi: 10.1136/bmj.b3129.
   PubMedGoogle Scholar
• Sibai BM. Evaluation and management of severe preeclampsia before 34 weeks’ gestation. Am J Obstet Gynecol. 2011;205(3):191–198. doi: 10.1016/j.ajog.2011.07.017.
   PubMed Web of Science ®Google Scholar
• Ukah UV, Payne B, Hutcheon JA, et al. Assessment of the fullPIERS risk prediction model in women with early-onset preeclampsia. Hypertension. 2018;71(4):659–665. doi: 10.1161/HYPERTENSIONAHA.117.10318.
   PubMed Web of Science ®Google Scholar
• Gazmararian JA, Petersen R, Jamieson DJ, et al. Hospitalizations during pregnancy among managed care enrollees. Obstet Gynecol. 2002;100(1):94–100. doi: 10.1016/s0029-7844(02)02024-0.
   PubMed Web of Science ®Google Scholar
• Callaghan WM, Mackay AP, Berg CJ. Identification of severe maternal morbidity during delivery hospitalizations, United States, 1991-2003. Am J Obstet Gynecol. 2008;199(2):133.e1–133.e8. doi: 10.1016/j.ajog.2007.12.020.
   PubMed Web of Science ®Google Scholar
• Bacak SJ, Callaghan WM, Dietz PM, et al. Pregnancy-associated hospitalizations in the United States, 1999-2000. Am J Obstet Gynecol. 2005;192(2):592–597. doi: 10.1016/j.ajog.2004.10.638.
   PubMed Web of Science ®Google Scholar
• Menzies J, Magee LA, Macnab YC, et al. Current CHS and NHBPEP criteria for severe preeclampsia do not uniformly predict adverse maternal or perinatal outcomes. Hypertens Pregnancy. 2007;26(4):447–462. doi: 10.1080/10641950701521742.
   PubMed Web of Science ®Google Scholar
• Ganzevoort W, Rep A, de Vries JI, et al. Prediction of maternal complications and adverse infant outcome at admission for temporizing management of early-onset severe hypertensive disorders of pregnancy. Am J Obstet Gynecol. 2006;195(2):495–503. doi: 10.1016/j.ajog.2006.02.012.
   PubMed Web of Science ®Google Scholar
• Anumba DO, Lincoln K, Robson SC. Predictive value of clinical and laboratory indices at first assessment in women referred with suspected gestational hypertension. Hypertens Pregnancy. 2010;29(2):163–179. doi: 10.3109/10641950902968635.
   PubMed Web of Science ®Google Scholar
• Klein E, Schlembach D, Ramoni A, et al. Influence of the sFlt-1/PlGF ratio on clinical Decision-Making in women with suspected preeclampsia. PLOS One. 2016;11(5):e0156013. doi: 10.1371/journal.pone.0156013.
   PubMed Web of Science ®Google Scholar
• Hund M, Allegranza D, Schoedl M, et al. Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol. BMC Pregnancy Childbirth. 2014;14(1):324. doi: 10.1186/1471-2393-14-324.
   PubMedGoogle Scholar
• Zeisler H, Llurba E, Chantraine F, et al. The sFlt-1: plGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374(1):13–22. doi: 10.1056/NEJMc1602338.
   PubMed Web of Science ®Google Scholar
• Chang YS, Chen CN, Jeng SF, et al. The sFlt-1/PlGF ratio as a predictor for poor pregnancy and neonatal outcomes. Pediatr Neonatol. 2017;58(6):529–533. doi: 10.1016/j.pedneo.2016.10.005.
   PubMed Web of Science ®Google Scholar
• Zeisler H, Llurba E, Chantraine F, et al. Predictive value of the sFlt-1: plGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374(1):13–22. doi: 10.1056/NEJMoa1414838.
   PubMed Web of Science ®Google Scholar
• Zeisler H, Llurba E, Chantraine F, et al. Soluble fms-Like tyrosine kinase-1-to-Placental growth factor ratio and time to delivery in women with suspected preeclampsia. Obstet Gynecol. 2016;128(2):261–269. doi: 10.1097/aog.0000000000001525.
   PubMed Web of Science ®Google Scholar
• Klunk WE, Jacob RF, Mason RP. Quantifying amyloid beta-peptide (abeta) aggregation using the Congo red-Abeta (CR-abeta) spectrophotometric assay. Anal Biochem. 1999;266(1):66–76. doi: 10.1006/abio.1998.2933.
   PubMed Web of Science ®Google Scholar
• Klunk WE, Jacob RF, Mason RP. Quantifying amyloid by Congo red spectral shift assay. Methods Enzymol. 1999;309:285–305. doi: 10.1016/s0076-6879(99)09021-7.
   PubMed Web of Science ®Google Scholar
• Knowles TP, Vendruscolo M, Dobson CM. The amyloid state and its association with protein misfolding diseases. Nat Rev Mol Cell Biol. 2014;15(6):384–396. doi: 10.1038/nrm3810.
   PubMed Web of Science ®Google Scholar
• Rood KM, Buhimschi CS, Dible T, et al. Congo red dot paper test for antenatal triage and rapid identification of preeclampsia. EClinicalMedicine. 2019;8:47–56. doi: 10.1016/j.eclinm.2019.02.004.
   PubMedGoogle Scholar
• Buhimschi IA, Nayeri UA, Zhao G, et al. Protein misfolding, congophilia, oligomerization, and defective amyloid processing in preeclampsia. Sci Transl Med. 2014;6(245):245ra92. doi: 10.1126/scitranslmed.3008808.
   PubMed Web of Science ®Google Scholar
• Buhimschi IA, Zhao G, Funai EF, et al. Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia. Am J Obstet Gynecol. 2008;199(5):551.e1–551.16. doi: 10.1016/j.ajog.2008.07.006.
   PubMed Web of Science ®Google Scholar
• Li XM, Liu XM, Xu J, et al. Late pregnancy screening for preeclampsia with a urinary point-of-care test for misfolded proteins. PLOS One. 2020;15(5):e0233214. doi: 10.1371/journal.pone.0233214.
   PubMed Web of Science ®Google Scholar
• Döbert M, Varouxaki AN, Mu AC, et al. Screening for late preeclampsia at 35-37 weeks by the urinary Congo-red dot paper test. J Matern Fetal Neonatal Med. 2022;35(25):5686–5690. doi: 10.1080/14767058.2021.1888924.
   PubMed Web of Science ®Google Scholar
• Wong STK, Sahota DS, Wong NKL, et al. A point-of care urine test to predict preeclampsia development in asian women with suspected preeclampsia. Pregnancy Hypertens. 2023;32:28–34. doi: 10.1016/j.preghy.2023.03.003.
   PubMed Web of Science ®Google Scholar
• Verlohren S, Herraiz I, Lapaire O, et al. New gestational phase-specific cutoff values for the use of the ­soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension. 2014;63(2):346–352. doi: 10.1161/hypertensionaha.113.01787.
   PubMed Web of Science ®Google Scholar
• McCarthy FP, Adetoba A, Gill C, et al. Urinary congophilia in women with hypertensive disorders of pregnancy and preexisting proteinuria or hypertension. Am J Obstet Gynecol. 2016;215(4):464.e1–464.e7. doi: 10.1016/j.ajog.2016.04.041.
   PubMed Web of Science ®Google Scholar